Pharma craters on Trump tariff. SMCI defies gravity.

Sell Teva Pharmaceutical⚡ — TEVA is directly exposed to US generics, and three sources flag the stock's decline on the tariff plan; last session it rose 1.1%, but the 2028 overhang is a structural headwind.

Sell Viatris⚡ — Viatris is another generic giant caught in the crossfire; the stock gained 3.5% last session, but the tariff announcement changes the earnings trajectory.

Sell Health Care Select⚡ — Broad healthcare sector ETF faces tariff uncertainty; XLV is only 3% below its 52-week high, leaving room for a pullback.

Sell India Earnings Fund⚡ — Indian pharma supplies the US generics market; EPI, down 10% YTD, could face further pressure if tariffs target key exports.

Buy Super Micro Computer — SMCI's unexpected margin doubling is a game-changer; the stock rallied 7% last session but at a forward P/E of 7.9, it remains cheap relative to the AI server growth story.

Buy VanEck Semiconductor ETF — SMCI's beat lifts all semiconductor boats; SMH gained 4.5% last session, and the AI buildout narrative supports further upside despite a YTD run of 56.5%.

Buy Long-duration Treasuries — Darda's call for lower yields implies a rally in long bonds; TLT is at its 52-week low, making the contrarian long appealing but reliant on a yield reversal.

Buy D.R. Horton — Home builders are the strategist's specific pick; DHI is down 5.3% in a week and trades at 12.1x forward earnings, making it a potential beneficiary if rates fall.

Buy Lennar — LEN also fits the home builder theme and has fallen 4% in a week; it trades at 0.9x book, suggesting deep value if the worst of the rate headwind passes.

Buy Deutsche Bank — DB trades at 7.4x forward earnings and 0.75x book, offering deep value if the Wall Street earnings wave crosses the Atlantic.

Buy UBS Group — UBS at 12.6x forward P/E and 1.76x book could see earnings upgrades as investment banking fees rebound, following the US trend.

Buy BNP Paribas — BNP Paribas has investment banking exposure, and while no specific data is available, it should benefit from the same tailwinds.

Buy Energy Select Sector — XLE trades at 21.7x trailing earnings after a 28% YTD run; the 'still cheap' thesis is tempting, but positioning is crowded.

Buy United States Oil Fund — Oil prices have surged 87% YTD; USO is near highs, and while the trend is up, a de-escalation could trigger a sharp reversal.

Buy Oil Services ETF — Oil services may also look cheap, but OIH is up 29.6% YTD; caution is warranted.

Buy China Large-Cap ETF — FXI could benefit if the mega-IPO reignites Hong Kong market enthusiasm; the ETF is down 13% YTD, leaving rerating upside.

Buy Hang Seng Index — A landmark listing would boost the Hong Kong index directly, and the HSI has been flat, offering a catalyst for upside.

Watch United States Copper Index Fund — Copper futures are near $14,000; CPER is near 52-week highs, and a tariff announcement could spark a breakout or breakdown.

Watch Freeport-McMoRan — Major copper producer FCX surged 6.4% last session; it's at 13% below its 52-week high and will be highly leveraged to the tariff decision.

Watch Southern Copper — SCCO jumped 7.4% last session and is 15% off its high; the stock moves with copper and carries geopolitical risk.

Watch Tesla — TSLA's valuation is stretched even after a 13.5% YTD decline; the stock remains 24% below its 52-week high, but the narrative gap is too wide to ignore.

Watch Ford — Ford trades at 7.8x forward earnings and could be a relative value play if the Tesla premium unwinds.

Watch General Motors — GM at 5.6x forward P/E is the cheapest of the legacy automakers; it surged 4.9% last session, possibly on rotation trades.